Nannocare

Minimize Discomfort, Maximize Life - Available in CVS Pharmacies!

Nannocare

Minimize Discomfort, Maximize Life - Available in CVS Pharmacies!

Los Angeles, CA
Consumer Products
E-Commerce
Offering women a revolutionary alternative to the out-dated menstrual products on the market today. Our Nannogenic technology uses far infrared energy, generated by the body, and safely concentrates it back into the pelvic area - improving blood circulation and relieving discomfort. Plus, we’re creating eco-friendly products with an aim to help the environment.

$25,584

raised
38
Investors
59
Days Left
$2.47
Price per Share
$14.8M
Valuation
Equity
Offering Type
$247.00
Min. Investment

$25,584

raised
38
Investors
59
Days Left
$2.47
Price per Share
$14.8M
Valuation
Equity
Offering Type
$247.00
Min. Investment

Reasons to Invest

Exclusive licensed Nannogenic™ Technology developed to relieve menstrual discomfort, proven by over 70% of users in user testings.
Sold at over 5K+ locations with a 95% reorder rate in the last quarter
Eco-friendly packaging that degrades in 1-3 years, 100% OCS Organic Cotton

Innovative sanitary pads, developed to naturally relieve menstrual discomfort with no drugs or medication.

42M women in the US suffer from painful menstrual cramps 

About 3.5M women are unable to function for one or two days each month because of severe dysmenorrhea. It’s the most common cause of lost work and school hours among women in the US. According to an article from the University of San Diego.

Most menstrual products on the market are out of date and harmful to the environment -  85M menstruating women in the US are limited to use products that can take up to 500 years to decompose, amounting to 12B pads and tampons in landfills yearly. 

An Eco-friendly solution, proven to alleviate 70% of users’ menstrual discomfort

Nannocare released the market’s first menstrual pad that targets relieving menstrual discomfort naturally. An Eco-friendly solution, proven to alleviate over 70% of users’ menstrual discomfort. 

Nannogenic's proprietary formulation absorbs the natural far infrared energy generated by the body and safely concentrate it back into the pelvic area - improving blood circulation thus to relieve discomfort. often reducing or eliminating the need for drugs and painkillers. Plus, our packaging is eco-friendly and can be bio-degraded within 1-3 years.

Feminine Hygiene is a massive industry

  • The average woman gets 500 periods in her lifetime; That leads to a $4,5K+ lifetime customer value for each loyal user

  • The global feminine hygiene market is projected to exceed $36B by 2024 as the rowing awareness about personal hygiene among women 

  • Women are becoming increasingly aware of the importance in using natural organic and environmentally-friendly products

Already in 4800+ retail locations and a 95% reorder rate

Nannocare has the exclusive license of its proprietary formulation and we’ve received a purchase order from CVS for 4.2K stores and anticipate subsequent orders to expand into all 9.8K+ stores. We’re being distributed across North America, the Caribbean, Canada and Mexico at top tier partners like Bristol Farms, Erewhon, BootsUK and more. And our retailers keep coming back: we garnered a 95% re-order rate in the last quarter.

Nannocare is growing fast:

  • Award-winning: 1st trade show - Won “Best of Show” Kehe trade show

  • Direct-To-Consumer: In 4,800+ stores and online

  • Press-Featured: Featured on Crunchbase, Forbes, Refinery 29, The Doctors TV show, and more... 

Innovation in a market that's had no advancement in decades

Based on our research, we have found that studies have shown that the use of far infrared energy has beneficial effects on circulation in the tiny blood vessels present within organ tissue, bringing discomfort and relief. We are using this technological advancement to help millions of women with menstrual discomfort. 

*Nannocare Inc has an exclusive license with Triple P Management who owns the Nannogenic technology and provides it for use in NannoPad® and other products sold and distributed exclusively by Nannocare Inc.

Proven results, eco-friendly, and safe

  • NannoPad's Nannogenic technology works with measurable effectiveness - it beats holistic remedies and doesn’t have the side effects of painkillers. We’ve conducted blind placebo testing in the UK along with two other in-house testing in the US and Asia with over 250 women. The result of menstrual relief is over 75%.

  • We use biodegradable plastic wrapping that can be degraded within 1-3 years - making us more ecofriendly than other disposable hygiene products. 

  • NannoPad is as thin as a nickel (2mm) and are still as absorbent or exceed other pads on the market, and have natural odor control without any fragrances. 

Eco-friendly, groundbreaking, menstrual relief at an affordable price

While our technology is more advanced, our pricing remains low. Our retail pricing is aligned with regular organic products, despite our products boasting ground-breaking, one-of-a-kind, menstrual-relief features. Nannocare will be sold on the shelves in all major pharmacies in North America and Europe. Soon, we’ll offer a product lineup that spans over 10 unique groundbreaking variations. 

30 years of combined gynecology experience

Nannocare is led by an established leadership team with significant experience scaling revolutionary products, magnificent global sourcing and distributing connections, and a medical team with over 30 years of combined gynecology experience.

Help us revolutionize feminine hygiene for 42M+ women

After decades of no advancements, we believe women deserve more. Join us in our eco-friendly mission to help alleviate menstrual discomfort for women using ground-breaking technology. Be a part of an industry-wide revolution.

Why Now? 

  • The awareness of women’s health is rising amongst the new generation of educated female shoppers.
  • The shame of openly talking about menstruation is ending.
  • The demand for natural and organic solutions is increasing.

*All perks occur after the offering is completed.

Offering Summary


Company

:

Nannocare Inc.

Corporate Address

:

1340 E 6th St, Los Angeles, CA 90021

Offering Minimum

:

$9,998.56

Offering Maximum

:

$106,997.93

Minimum Investment Amount

(per investor)

:

$247.00











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

4,048

Maximum Number of Shares Offered*

:

43,319

Price per Share

:

$2.47

Pre-Money Valuation

:

$14,762,572.50










*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below


Investment Bonuses* and Perks


Early Bird Bonsues

First 7 days - 25% bonus shares

Next 14 days - 10% bonus shares


Volume Based Bonuses and Perks

$247+ (Thank you card from founders + 1 month supply FREE NannoPads)

$500+($50 credit for purchase on Nannocare.com + 2 month supply of NannoPads)

$1,000+ (5% lifetime discount for online purchase on Nannocare.com + 3 months supply of Nannopads)

$3,000+ (10% lifetime discount for online purchase on Nannocare.com + 3 months supply of Nannopads)

$5,000+ (10% discount lifetime for online purchase on Nannocare.com + 6 months supply of nannopads + 5% bonus shares)

$10,000+ (15% discount lifetime for online purchase on Nannocare.com + 9 months supply of nannopads + 10% bonus shares)

$20,000+ (15% discount lifetime for online purchase on Nannocare.com + One year supply + 15% bonus shares)

$35,000+ (20% discount lifetime for online purchase on Nannocare.com + One year supply + 20% bonus shares)

*All perks occur after the offering is completed.


The 10% Bonus for StartEngine Shareholders

Nannocare Inc. will offer 10% additional bonus shares for all investments that are committed by StartEngine Crowdfunding Inc. shareholders who invested over $1,000 or made at least two investments in StartEngine's own offerings.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $2.47 / share, you will receive 110 Common Stock shares, meaning you'll own 110 shares for $247. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid for one year from the time StartEngine Crowdfunding Inc. investors receive their countersigned StartEngine Crowdfunding Inc. subscription agreement, unless their eligibility period has been extended through additional subsequent investments in StartEngine's own offerings.  

Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.

Irregular Use of Proceeds

The Company will not incur any irregular use of proceeds.

Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$185,565.00 USD
$50,016.00 USD
Cash And Cash Equivalents
$0.00 USD
$50,016.00 USD
Accounts Receivable
$28,131.00 USD
$0.00 USD
Short Term Debt
$86,456.00 USD
$0.00 USD
Long Term Debt
$151,580.00 USD
$0.00 USD
Revenues And Sales
$47,581.00 USD
$0.00 USD
Costs Of Goods Sold
$8,189.00 USD
$17,524.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$377,487.00 USD
-$49,984.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

Follow Nannocare to get notified of future updates!

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}